Patent · US Active

Process for stereospecific synthesis of vitamin K2 and its novel intermediates

US11912654B2 · kind B2 · utility

0Cited by
8References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 29, 2022
Grant dateFeb 27, 2024
Priority date
Expiry dateApr 29, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2603/88
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure relates to a novel process for the synthesis of stereospecific compounds of Vitamin K2 group in general and Vitamin K2-7. The present disclosure further discloses novel intermediates useful in the synthesis of stereospecific Vitamin K2-7. Compounds of the Vitamin K2 group obtained are crystalline and exhibit well defined melting points.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.